{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T19:25:35Z","timestamp":1783106735120,"version":"3.54.6"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001502","name":"Department of Atomic Energy, Government of India","doi-asserted-by":"publisher","award":["RSI4002"],"award-info":[{"award-number":["RSI4002"]}],"id":[{"id":"10.13039\/501100001502","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12035-026-06024-2","type":"journal-article","created":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T17:17:13Z","timestamp":1783099033000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["miR-6836-5p Drives Astrocyte Pro-survival Signaling Through DLG2-Hippo-YAP Pathway Under AQP4-IgG\u2009+\u2009ve NMOSD Stress"],"prefix":"10.1007","volume":"63","author":[{"given":"Pallavi","family":"Chatterjee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santosh","family":"Trivedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashis","family":"Datta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4516-2260","authenticated-orcid":false,"given":"Debashis","family":"Mukhopadhyay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,3]]},"reference":[{"key":"6024_CR1","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","volume":"364","author":"VA Lennon","year":"2004","unstructured":"Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K et al (2004) A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 364:2106\u20132112","journal-title":"Lancet"},{"key":"6024_CR2","doi-asserted-by":"publisher","first-page":"22","DOI":"10.33588\/rn.7401.2021163","volume":"74","author":"M Sep\u00falveda G\u00e1zquez","year":"2022","unstructured":"Sep\u00falveda G\u00e1zquez M, Arrambide G, Cobo Calvo \u00c1 (2022) Epidemiolog\u00eda del espectro de neuromielitis \u00f3ptica. Nuevos y viejos desaf\u00edos. Rev Neurol 74:22","journal-title":"Rev Neurol"},{"key":"6024_CR3","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s12974-022-02450-w","volume":"19","author":"J-W Hyun","year":"2022","unstructured":"Hyun J-W, Kim Y, Kim KH, Kim S-H, Olesen MN, Asgari N et al (2022) CSF GFAP levels in double seronegative neuromyelitis optica spectrum disorder: no evidence of astrocyte damage. J Neuroinflammation 19:86","journal-title":"J Neuroinflammation"},{"key":"6024_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232314559","volume":"23","author":"AL Spiezia","year":"2022","unstructured":"Spiezia AL, Carotenuto A, Iovino A, Moccia M, Gastaldi M, Iodice R et al (2022) AQP4-MOG double-positive neuromyelitis optica spectrum disorder: case report with central and peripheral nervous system involvement and review of literature. Int J Mol Sci 23:14559","journal-title":"Int J Mol Sci"},{"key":"6024_CR5","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","volume":"85","author":"DM Wingerchuk","year":"2015","unstructured":"Wingerchuk DM, Banwell B, Bennett JL, Cabre P, Carroll W, Chitnis T et al (2015) International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 85:177\u2013189","journal-title":"Neurology"},{"key":"6024_CR6","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1620\/tjem.197.87","volume":"197","author":"M Inoue","year":"2002","unstructured":"Inoue M, Wakayama Y, Liu JW, Murahashi M, Shibuya S, Oniki H (2002) Ultrastructural Localization of Aquaporin 4 and .ALPHA.1-Syntrophin in the Vascular Feet of Brain Astrocytes. Tohoku J Exp Med 197:87\u201393","journal-title":"Tohoku J Exp Med"},{"key":"6024_CR7","doi-asserted-by":"crossref","unstructured":"Palazzo C, Buccoliero C, Mola MG, Abbrescia P, Nicchia GP, Trojano M et al (2019) AQP4ex is crucial for the anchoring of AQP4 at the astrocyte end-feet and for neuromyelitis optica antibody binding. Acta Neuropathol Commun 7(1):51","DOI":"10.1186\/s40478-019-0707-5"},{"key":"6024_CR8","doi-asserted-by":"publisher","first-page":"16516","DOI":"10.1074\/jbc.M111.227298","volume":"286","author":"JM Crane","year":"2011","unstructured":"Crane JM, Lam C, Rossi A, Gupta T, Bennett JL, Verkman AS (2011) Binding Affinity and Specificity of Neuromyelitis Optica Autoantibodies to Aquaporin-4 M1\/M23 Isoforms and Orthogonal Arrays. J Biol Chem 286:16516\u201316524","journal-title":"J Biol Chem"},{"key":"6024_CR9","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1212\/01.WNL.0000289761.64862.ce","volume":"69","author":"SR Hinson","year":"2007","unstructured":"Hinson SR, Pittock SJ, Lucchinetti CF, Roemer SF, Fryer JP, Kryzer TJ et al (2007) Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica. Neurology 69:2221\u20132231","journal-title":"Neurology"},{"key":"6024_CR10","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1093\/brain\/awf151","volume":"125","author":"CF Lucchinetti","year":"2002","unstructured":"Lucchinetti CF (2002) A role for humoral mechanisms in the pathogenesis of Devic\u2019s neuromyelitis optica. Brain 125:1450\u20131461","journal-title":"Brain"},{"key":"6024_CR11","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/s12974-015-0403-8","volume":"12","author":"ME Walker-Caulfield","year":"2015","unstructured":"Walker-Caulfield ME, Guo Y, Johnson RK, McCarthy CB, Fitz-Gibbon PD, Lucchinetti CF et al (2015) NF\u03baB signaling drives pro-granulocytic astroglial responses to neuromyelitis optica patient IgG. J Neuroinflammation 12:185","journal-title":"J Neuroinflammation"},{"key":"6024_CR12","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s40001-022-00723-x","volume":"27","author":"H Qiao","year":"2022","unstructured":"Qiao H, Mao Z, Wang W, Chen X, Wang S, Fan H et al (2022) Changes in the BTK\/NF-\u03baB signaling pathway and related cytokines in different stages of neuromyelitis optica spectrum disorders. Eur J Med Res 27:96","journal-title":"Eur J Med Res"},{"key":"6024_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.118217","volume":"258","author":"L Du","year":"2020","unstructured":"Du L, Chang H, Xu W, Wei Y, Wang Y, Yin L et al (2020) Effect of NMO-IgG on the interleukin-6 cascade in astrocytes via activation of the JAK\/STAT3 signaling pathway. Life Sci 258:118217","journal-title":"Life Sci"},{"key":"6024_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2021.577752","volume":"361","author":"S Saha","year":"2021","unstructured":"Saha S, Mukherjee S, Guha G, Mukhopadhyay D (2021) Dynamics of AQP4 upon exposure to seropositive patient serum before and after Rituximab therapy in neuromyelitis optica: a cell-based study. J Neuroimmunol 361:577752","journal-title":"J Neuroimmunol"},{"key":"6024_CR15","first-page":"167922","volume":"7","author":"N Mangoud","year":"1871","unstructured":"Mangoud N, Hegazy MI, Estfanous S (1871) Ali SA (2025) The lncRNA 74.1\/miR-324\u20133p\/NRG1 axis as a differential diagnostic and prognostic biomarker in neuromyelitis optica and multiple sclerosis. Biochim Biophys Acta Mol Basis Dis 7:167922","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"1","key":"6024_CR16","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1002\/ana.26650","volume":"94","author":"Y Xie","year":"2023","unstructured":"Xie Y, Chen B, Wang Q, Chen X, Lai W, Xu Y, Deng S, Yu Z et al (2023) Astrocyte-derived exosomes contribute to pathologies of Neuromyelitis Optica spectrum disorder in rodent model. Ann Neurol 94(1):163\u2013181","journal-title":"Ann Neurol"},{"key":"6024_CR17","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/s12974-016-0648-x","volume":"13","author":"A Vaknin-Dembinsky","year":"2016","unstructured":"Vaknin-Dembinsky A, Charbit H, Brill L, Abramsky O, Gur-Wahnon D, Ben-Dov IZ et al (2016) Circulating microRNAs as biomarkers for rituximab therapy, in neuromyelitis optica (NMO). J Neuroinflammation 13:179","journal-title":"J Neuroinflammation"},{"key":"6024_CR18","volume":"11","author":"C Chen","year":"2020","unstructured":"Chen C, Wu Y, Li M, Cui C, Zhao Y, Sun X et al (2020) Different exosomal microRNA profile in Aquaporin-4 antibody positive Neuromyelitis Optica spectrum disorders. Front Immunol 11:106","journal-title":"Front Immunol"},{"issue":"2","key":"6024_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2024.114375","volume":"444","author":"P Chatterjee","year":"2025","unstructured":"Chatterjee P, Chakravarty S, Biswas NK, Trivedi S, Datta A, Mukhopadhyay D (2025) Small RNA sequencing of differentiated astrocytoma exposed to NMOSD patient sera reveals perturbations in neurodegenerative signaling. Exp Cell Res 444(2):114375","journal-title":"Exp Cell Res"},{"key":"6024_CR20","doi-asserted-by":"publisher","first-page":"103302","DOI":"10.1016\/j.dnarep.2022.103302","volume":"112","author":"S Keane","year":"2022","unstructured":"Keane S, de Weerd HA, Ejesk\u00e4r K (2022) DLG2 impairs dsDNA break repair and maintains genome integrity in neuroblastoma. DNA Repair (Amst) 112:103302","journal-title":"DNA Repair (Amst)"},{"issue":"6","key":"6024_CR21","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1080\/15384047.2019.1579960","volume":"20","author":"RJ Zhuang","year":"2019","unstructured":"Zhuang RJ, Bai XX, Liu W (2019) MicroRNA-23a depletion promotes apoptosis of ovarian cancer stem cell and inhibits cell migration by targeting DLG2. Cancer Biol Ther 20(6):897\u2013911","journal-title":"Cancer Biol Ther"},{"key":"6024_CR22","doi-asserted-by":"publisher","first-page":"e10455","DOI":"10.1371\/journal.pone.0010455","volume":"5","author":"S Mader","year":"2010","unstructured":"Mader S, Lutterotti A, Di Pauli F, Kuenz B, Schanda K, Aboul-Enein F et al (2010) Patterns of antibody binding to aquaporin-4 Isoforms in Neuromyelitis Optica. Kleinschnitz C, editor. PLoS ONE 5:e10455","journal-title":"PLoS ONE"},{"key":"6024_CR23","first-page":"77","volume":"7","author":"P Huang","year":"2016","unstructured":"Huang P, Takai Y, Kusano-Arai O, Ramadhanti J, Iwanari H, Miyauchi T, Sakihama T, Han J-Y et al (2016) The binding property of a monoclonal antibody against the extracellular domains of aquaporin-4 directs aquaporin-4 toward endocytosis. Biochem Biophys Rep 7:77\u201383","journal-title":"Biochem Biophys Rep"},{"key":"6024_CR24","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212\u0394\u0394CT method. Methods 25:402\u2013408","journal-title":"Methods"},{"key":"6024_CR25","doi-asserted-by":"crossref","unstructured":"Chen Y, Wang X (2020) miRDB: an online database for prediction of functional microRNA targets. http:\/\/mirdb.org\/. Accessed","DOI":"10.1093\/nar\/gkz757"},{"key":"6024_CR26","doi-asserted-by":"crossref","unstructured":"McGeary SE, Lin KS, Shi CY, Pham T, Bisaria N, Kelley GM, Bartel DP (2019) The biochemical basis of microRNA targeting efficacy. https:\/\/www.targetscan.org\/vert_80\/. Accessed","DOI":"10.1101\/414763"},{"key":"6024_CR27","doi-asserted-by":"crossref","unstructured":"Kern F, Aparicio-Puerta E, Li Y, Fehlmann T, Kehl T, Wagner V, Ray K, Ludwig N et al (2021) miRTargetLink 2.0\u2014interactive miRNA target gene and target pathway networks. https:\/\/ccb-compute.cs.uni-saarland.de\/mirtargetlink2. Accessed","DOI":"10.1093\/nar\/gkab297"},{"key":"6024_CR28","doi-asserted-by":"crossref","unstructured":"Tastsoglou S, Alexiou A, Karagkouni D, Skoufos G, Zacharopoulou E, Hatzigeorgiou A (2023) DIANA-microT 2023: including predicted targets of virally encoded miRNAs. https:\/\/dianalab.e-ce.uth.gr\/microt_webserver\/#\/ . Accessed","DOI":"10.1093\/nar\/gkad283"},{"key":"6024_CR29","doi-asserted-by":"crossref","unstructured":"Huang H, Lin Y, Cui S, Huang Y, Tang Y, Xu J, Bao J, Li Y et al (2022) miRTarBase update 2022: an informative resource for experimentally validated miRNA-target interactions. https:\/\/mirtarbase.cuhk.edu.cn\/~miRTarBase\/miRTarBase_2022\/php\/index.php. Accessed","DOI":"10.1093\/nar\/gkab1079"},{"key":"6024_CR30","doi-asserted-by":"crossref","unstructured":"Xie Z, Bailey A, Kuleshov MV, Clarke DJB, Evangelista JE, Jenkins SL, Lachmann A, Wojciechowicz ML et al (2021) Gene set knowledge discovery with Enrichr. 2021. https:\/\/maayanlab.cloud\/Enrichr\/. Accessed","DOI":"10.1002\/cpz1.90"},{"issue":"8","key":"6024_CR31","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1080\/14712598.2021.1884223","volume":"21","author":"N Asavapanumas","year":"2021","unstructured":"Asavapanumas N, Tradtrantip L, Verkman AS (2021) Targeting the complement system in neuromyelitis optica spectrum disorder. Expert Opin Biol Ther 21(8):1073\u20131086","journal-title":"Expert Opin Biol Ther"},{"issue":"1","key":"6024_CR32","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s40478-019-0766-7","volume":"7","author":"T Duan","year":"2019","unstructured":"Duan T, Smith AJ, Verkman AS (2019) Complement-independent bystander injury in AQP4-IgG seropositive neuromyelitis optica produced by antibody-dependent cellular cytotoxicity. Acta Neuropathol Commun 7(1):112","journal-title":"Acta Neuropathol Commun"},{"issue":"10","key":"6024_CR33","doi-asserted-by":"publisher","first-page":"678","DOI":"10.34172\/aim.2020.86","volume":"23","author":"W Sharaf-Eldin","year":"2020","unstructured":"Sharaf-Eldin W, Kishk N, Sakr B, El-Hariri H, Refeat M, ElBagoury N, Essawi M (2020) Potential value of miR-23a for discriminating neuromyelitis optica spectrum disorder from multiple sclerosis. Arch Iran Med 23(10):678\u2013687","journal-title":"Arch Iran Med"},{"issue":"11","key":"6024_CR34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0314446","volume":"19","author":"S Bakhashab","year":"2024","unstructured":"Bakhashab S, Banafea GH, Ahmed F, Bagatian N, Subhi O, Schulten HJ, Pushparaj PN (2024) Interleukin-33 mediated regulation of microRNAs in human cord blood-derived mast cells: implications for infection, immunity, and inflammation. PLoS ONE 19(11):e0314446","journal-title":"PLoS ONE"},{"issue":"1","key":"6024_CR35","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12935-022-02509-x","volume":"22","author":"X Wan","year":"2022","unstructured":"Wan X, Xie B, Sun H, Gu W, Wang C, Deng Q, Zhou S (2022) Exosomes derived from M2 type tumor-associated macrophages promote osimertinib resistance in non-small cell lung cancer through MSTRG.292666.16-miR-6836-5p-MAPK8IP3 axis. Cancer Cell Int 22(1):83","journal-title":"Cancer Cell Int"},{"issue":"1","key":"6024_CR36","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s10528-022-10259-8","volume":"61","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Hu J, Li T, Hao S, Wu X (2023) Construction of a diagnostic model for distinguishing benign or malignant bone cancer by mining miRNA expression data. Biochem Genet 61(1):299\u2013315","journal-title":"Biochem Genet"},{"key":"6024_CR37","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/s41392-022-01191-9","volume":"7","author":"M Fu","year":"2022","unstructured":"Fu M, Hu Y, Lan T (2022) The Hippo signalling pathway and its implications in human health and diseases. Sig Transduct Target Ther 7:376","journal-title":"Sig Transduct Target Ther"},{"issue":"4","key":"6024_CR38","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/nrc3458","volume":"13","author":"KF Harvey","year":"2013","unstructured":"Harvey KF, Zhang X, Thomas DM (2013) The Hippo pathway and human cancer. Nat Rev Cancer 13(4):246\u2013257","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"6024_CR39","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.ccell.2016.05.005","volume":"29","author":"F Zanconato","year":"2016","unstructured":"Zanconato F, Cordenonsi M, Piccolo S (2016) YAP\/TAZ at the roots of cancer. Cancer Cell 29(6):783\u2013803","journal-title":"Cancer Cell"},{"issue":"6","key":"6024_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/cells10061416","volume":"10","author":"Q Liu","year":"2021","unstructured":"Liu Q, Liu X, Song G (2021) The hippo pathway: a master regulatory network important in cancer. Cells 10(6):1416","journal-title":"Cells"},{"issue":"1","key":"6024_CR41","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/s41467-020-14353-6","volume":"11","author":"H Tanaka","year":"2020","unstructured":"Tanaka H, Homma H, Fujita K, Kondo K, Yamada S, Jin X, Waragai M, Ohtomo G et al (2020) YAP-dependent necrosis occurs in early stages of Alzheimer\u2019s disease and regulates mouse model pathology. Nat Commun 11(1):507","journal-title":"Nat Commun"},{"issue":"22","key":"6024_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/cells11223631","volume":"11","author":"P Sileo","year":"2022","unstructured":"Sileo P, Simonin C, Melnyk P, Chartier-Harlin MC, Cotelle P (2022) Crosstalk between the Hippo pathway and the Wnt pathway in Huntington\u2019s disease and other neurodegenerative disorders. Cells 11(22):3631","journal-title":"Cells"},{"key":"6024_CR43","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.bbr.2018.08.003","volume":"356","author":"P Gong","year":"2019","unstructured":"Gong P, Zhang Z, Zou C, Tian Q, Chen X, Hong M, Liu X, Chen Q et al (2019) Hippo\/YAP signaling pathway mitigates blood-brain barrier disruption after cerebral ischemia\/reperfusion injury. Behav Brain Res 356:8\u201317","journal-title":"Behav Brain Res"},{"issue":"17","key":"6024_CR44","doi-asserted-by":"publisher","first-page":"8480","DOI":"10.7150\/thno.60031","volume":"11","author":"Q Wu","year":"2021","unstructured":"Wu Q, Miao X, Zhang J, Xiang L, Li X, Bao X, Du S, Wang M et al (2021) Astrocytic YAP protects the optic nerve and retina in an experimental autoimmune encephalomyelitis model through TGF-\u03b2 signaling. Theranostics 11(17):8480\u20138499","journal-title":"Theranostics"},{"issue":"10","key":"6024_CR45","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/s41419-021-04203-8","volume":"12","author":"J Zhang","year":"2021","unstructured":"Zhang J, Xu X, Liu H, Jin L, Shen X, Xie C, Xiang W, Yang D et al (2021) Astrocytic YAP prevents the demyelination through promoting expression of cholesterol synthesis genes in experimental autoimmune encephalomyelitis. Cell Death Dis 12(10):907","journal-title":"Cell Death Dis"},{"issue":"10","key":"6024_CR46","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.jgg.2011.09.005","volume":"38","author":"M Enomoto","year":"2011","unstructured":"Enomoto M, Igaki T (2011) Deciphering tumor-suppressor signaling in flies: genetic link between Scribble\/Dlg\/Lgl and the Hippo pathways. J Genet Genomics 38(10):461\u2013470","journal-title":"J Genet Genomics"},{"issue":"10","key":"6024_CR47","doi-asserted-by":"publisher","first-page":"3099","DOI":"10.7150\/ijbs.83264","volume":"19","author":"Y Zou","year":"2023","unstructured":"Zou Y, Zhao Z, Wang J, Ma L, Liu Y, Sun L, Song Y (2023) Extracellular vesicles carrying miR-6836 derived from resistant tumor cells transfer cisplatin resistance of epithelial ovarian cancer via DLG2-YAP1 signaling pathway. Int J Biol Sci 19(10):3099\u20133114","journal-title":"Int J Biol Sci"},{"issue":"1","key":"6024_CR48","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s41065-025-00365-z","volume":"162","author":"M Pu","year":"2025","unstructured":"Pu M, Xiao X, Lv S, Ran D, Huang Q, Zhou M, Lei Q, Kong L et al (2025) METTL3-dependent DLG2 inhibits the malignant progression of cervical cancer by inactivating the Hippo\/YAP signaling. Hereditas 162(1):9","journal-title":"Hereditas"},{"issue":"12","key":"6024_CR49","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1002\/mc.23259","volume":"59","author":"S Li","year":"2020","unstructured":"Li S, Yan G, Liu W, Li C, Wang X (2020) Circ0106714 inhibits tumorigenesis of colorectal cancer by sponging miR-942-5p and releasing DLG2 via Hippo-YAP signaling. Mol Carcinog 59(12):1323\u20131342","journal-title":"Mol Carcinog"},{"issue":"8","key":"6024_CR50","doi-asserted-by":"publisher","first-page":"3482","DOI":"10.1158\/0008-5472.CAN-08-2524","volume":"69","author":"MY Wang","year":"2009","unstructured":"Wang MY, Chen PS, Prakash E, Hsu HC, Huang HY, Lin MT, Chang KJ, Kuo ML (2009) Connective tissue growth factor confers drug resistance in breast cancer through concomitant up-regulation of Bcl-xL and cIAP1. Cancer Res 69(8):3482\u20133491","journal-title":"Cancer Res"},{"key":"6024_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/srep34018","volume":"6","author":"X Zhu","year":"2016","unstructured":"Zhu X, Song Y, Wu C, Pan C, Lu P, Wang M, Zheng P, Huo R et al (2016) Cyr61 participates in the pathogenesis of acute lymphoblastic leukemia by enhancing cellular survival via the AKT\/NF-\u03baB signaling pathway. Sci Rep 6:34018","journal-title":"Sci Rep"},{"issue":"21","key":"6024_CR52","doi-asserted-by":"publisher","first-page":"7724","DOI":"10.1158\/0008-5472.CAN-04-1085","volume":"64","author":"G Regl","year":"2004","unstructured":"Regl G, Kasper M, Schnidar H, Eichberger T, Neill GW, Philpott MP, Esterbauer H, Hauser-Kronberger C et al (2004) Activation of the BCL2 promoter in response to Hedgehog\/GLI signal transduction is predominantly mediated by GLI2. Cancer Res 64(21):7724\u20137731","journal-title":"Cancer Res"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-06024-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-026-06024-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-06024-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T19:02:38Z","timestamp":1783105358000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-026-06024-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["6024"],"URL":"https:\/\/doi.org\/10.1007\/s12035-026-06024-2","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"29 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was carried out in collaboration with the Institute of Neurosciences, Kolkata (INK), after receiving approval from the Institutional Ethical Committee (INK\/NEUROLOGY\/PATHOPHY\/NMOSD_PROL-01\/2021\/Ver.01 dated: November 15, 2021), and after obtaining written informed consent from the family members of each patient during blood collection.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"All the coauthors consented to this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"741"}}